Study: 46.7 million Americans have Alzheimer’s Disease brain pathology today, so it’s urgent to prevent or at least delay progression to clinical disease

New fore­cast shows 6 mil­lion with Alzheimer’s dis­ease, cog­ni­tive impair­ment; The num­bers will more than dou­ble to 15 mil­lion by 2060 (NIH news): “Using new method­ol­o­gy, sci­en­tists cal­cu­late that approx­i­mate­ly 6 mil­lion Amer­i­can adults have Alzheimer’s dis­ease or mild cog­ni­tive impair­ment, which can some­times be a pre­cur­sor to the dis­ease. The esti­mate, fund­ed by the National…

Read More

Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers

_______ The hunt for behav­ioral health bio­mark­ers is har­ness­ing dig­i­tal health at the research stage (Med­C­i­ty News): “Dig­i­tal health com­pa­nies are going through an inter­est­ing trans­for­ma­tion as research insti­tu­tions real­ize the ben­e­fit of their tech­nol­o­gy to col­lect and man­age data for a host of stud­ies. The bio­phar­ma industry’s embrace of some dig­i­tal health tools to manage…

Read More

Cognitive Training or Gingko Biloba to prevent cognitive decline and dementia? New comprehensive report by the National Academies of Sciences, Engineering, and Medicine clarifies priorities for public health and for future research

Evi­dence Sup­port­ing Three Inter­ven­tions That Might Slow Cog­ni­tive Decline and the Onset of Demen­tia Is Encour­ag­ing but Insuf­fi­cient to Jus­ti­fy a Pub­lic Health Cam­paign Focused on Their Adop­tion (Nation­al Acad­e­mies of Sci­ences, Engi­neer­ing, and Med­i­cine): “Cog­ni­tive train­ing, blood pres­sure man­age­ment for peo­ple with hyper­ten­sion, and increased phys­i­cal activ­i­ty all show mod­est but incon­clu­sive evi­dence that…

Read More

Systematic evidence review finds cognitive behavioral therapy as effective as antidepressant medicines in treating depression

Depres­sion: Treat­ment Beyond Med­ica­tion (The Dana Foun­da­tion): “Major depres­sive dis­or­der affects near­ly 7 per­cent of peo­ple in the US aged 18 and up, accord­ing to the Depres­sion and Bipo­lar Sup­port Alliance. Those who seek treat­ment will most like­ly be pre­scribed a sec­ond-gen­er­a­­tion anti­de­pres­sant med­ica­tion such as a selec­tive sero­tonin reup­take inhibitor (SSRI), tri­cyclic anti­de­pres­sant (TCA),…

Read More

Study: Brain imaging not accurate or sensitive enough (yet) to detect Alzheimer’s disease in primary care settings

Accu­ra­cy of demen­tia brain imag­ing must improve (Uni­ver­si­ty of East Anglia release): “A report pub­lished today in The Lancet Neu­rol­o­gy eval­u­ates for the first time how well dif­fer­ent types of brain imag­ing tests work to detect Alzheimer’s and pre­dict how the dis­ease will progress. The results show that the accu­ra­cy of brain imag­ing must be…

Read More